The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Abbott Laboratories’s current trading price is -2.89% away from its 52-week high, while its distance from the 52-week low is 31.73%. The stock’s price range for this period has been between $89.67 and $121.64 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.98 million for the day, a number notably lower than the average daily volume of 6.08 million over the last three months.
In terms of market performance, Abbott Laboratories had a fairly even. The highest value for the stock in the past year was $121.64 on 03/08/24, and the lowest value was recorded at $89.67 on 10/12/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Abbott Laboratories (ABT) has experienced a quarterly rise of 14.19% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 205.53B and boasts a workforce of 114000 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 107.07, with a change in price of +11.24. Similarly, Abbott Laboratories recorded 5,882,159 in trading volume during the last 100 days, posting a change of +10.52%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABT stands at 0.38. Similarly, the long-term debt-to-equity ratio is also 0.33.
ABT Stock Stochastic Average
Abbott Laboratories’s raw stochastic average for the past 50 days is presently 97.82%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 95.01%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 93.78% and 92.81%, respectively.
ABT Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 7.32% this year. Over the last six months, there has been a weaker performance of 5.06%. The price of ABT fallen by 6.42% during the last 30 days period. For the last 5-days stocks have improved 0.87%.
